Moderna Secures European Contract For Covid-19 Vaccine
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
pharmaphorum5d
Moderna follows Pfizer in asking FDA for second COVID booster okay
Moderna has asked the FDA for emergency use authorisation for a fourth dose of its mRNA COVID-19 vaccine SpikeVax ... Pfizer's application was from an open-label study in Israel involving ...
Newsweek23d
Moderna Shares Plunge After Predicting Steep 2025 Sales Decline
Pharmacist Kim Nguyen administers a Moderna Spikevax COVID-19 vaccine at a CVS, Wednesday, Sept. 20, 2023, in Cypress, Texas. Weak adoption of Moderna’s respiratory syncytial virus (RSV ...
Seeking Alpha22d
Moderna's Road To Stopping The Red
Moderna is down 80% from its 52-week high as ... like potential approval of a next-gen COVID vaccine and a possible label expansion for the RSV vaccine due in 2025. An opportunity for an early ...
Moderna Receives EU Tender Order for Covid-19 Vaccine
Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was ...
Newsday24d
Moderna surprises the Street by predicting a bigger-than-expected sales drop
Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. Regulators also approved a Moderna vaccine for RSV, or ...
Moderna Hold Recommendation Amid Reduced Revenue Projections and Price Target
In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...